3rd Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Oppose medical device tariffs.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Taxation/Internal Revenue Code TAX

Support repeal of medical device tax.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Address concerns with changes to Medicare Part B and Part D programs, and Hospital Outpatient Prospective Payment System. Address concerns with Medicare Advantage step therapy proposal. Support Advancing Access to Precision Medicine Act. Support Ensuring Patient Access to Critical Breakthrough Products Act.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation; FDA Appropriations; PTO Appropriations.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Support NIH research funding. Support implementation of 21st Century Cures Act.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Copyright/Patent/Trademark CPT

Address concerns with provisions of patent litigation reform, including inter partes review. Support STRONGER Patents Act. Educate on Bayh-Dole Act "march-in" provision.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Health Issues HCR

Support FDA user fee programs and review process consistency and predictability. Support PAHPA re- authorization. Support policy improvements to address antimicrobial resistance. Address concerns with pharmacies compounding Non- Biologic Complex Drugs.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
ADAM LOTSPIKE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.